ni2o, Inc.

A spinout of Oxford University, founded by a global team of experienced entrepreneurs, technologists, and neuroscientists, ni2o is continuing the work started by MIT’s Mind Machine Project – developing a revolutionary brain-computer interface (BCI) that addresses the most pressing and costly medical needs of a rapidly aging global population, the treatment of neurodegenerative brain diseases and disorders. ni2o is an exciting new project in neuroscience with a vision to cure all brain disorders. We are committed to a future where brain health is democratized, accessible and affordable to everyone thereby restoring their human dignity.